返回今日信号

TECH

NMS
Bio-Techne Corporation
医疗保健 Biotechnology United States 官网
$71.00
+0.42% 当日
AI选股 2 条

AI选股记录

次日看涨Top3 #1 评分 76 概率 63%

这个股票来自自动 AI 选股池。以后只要 CLI 写入新的 ticker,这里会自动生成个股页面,不需要手工补页面。

2026-06-26 · AI选股池
默克KGaA拟以73美元现金收购Bio-Techne,放量跳涨后仍贴近要约价

催化明确、来源质量高、成交量远超均量,且市值和流动性满足过滤条件;排名受限于73美元现金要约价带来的短线空间上限。

风险提示:价格已接近73美元现金要约价,短线收益空间可能被压缩; 若监管、股东审批或竞购预期降温,价差可能扩大
该股票的历史 AI 入选记录
2026-06-26
次日看涨Top3 #1
默克KGaA拟以73美元现金收购Bio-Techne,放量跳涨后仍贴近要约价
催化明确、来源质量高、成交量远超均量,且市值和流动性满足过滤条件;排名受限于73美元现金要约价带来的短线空间上限。
76
2026-06-26
次日看涨Top3 #1
TECH
催化明确、来源质量高、成交量远超均量,且市值和流动性满足过滤条件;排名受限于73美元现金要约价带来的短线空间上限。
76
查看AI历史

基本信息

市值
$11.06B
市盈率 TTM
101.43
前瞻市盈率
34.65
股息率
45.00%
52周高点
$72.16
52周低点
$43.20
Beta
1.36
日均成交量
3.71M

成交结构

基于近 60 日量价数据观察资金强弱。

截至 2026-06-26
资金流强弱 MFI
92.0
严重超买
Chaikin 资金流 CMF
+0.291
强净流入
量能变化
2.3x
暴量
空头持仓比
13.26%
中等

交易信号历史

按时间回看该股票被模型捕捉到的买点信号。

共 0 条

公司简介

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.

员工数量 3,100 总部 Minneapolis, United States

最新资讯

外部数据 Yahoo Finance MarketWatch Stock Analysis Seeking Alpha